Details for New Drug Application (NDA): 020738
✉ Email this page to a colleague
The generic ingredient in TEVETEN is eprosartan mesylate; hydrochlorothiazide. There are eleven drug master file entries for this compound. Additional details are available on the eprosartan mesylate; hydrochlorothiazide profile page.
Summary for 020738
Tradename: | TEVETEN |
Applicant: | Abbvie |
Ingredient: | eprosartan mesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 22, 1997 | TE: | RLD: | No |
Profile for product number 005
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 22, 1997 | TE: | RLD: | Yes |
Profile for product number 006
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 27, 1999 | TE: | RLD: | Yes |
Expired US Patents for NDA 020738
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-006 | May 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-004 | Dec 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-005 | Dec 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-004 | Dec 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-005 | Dec 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | TEVETEN | eprosartan mesylate | TABLET;ORAL | 020738-006 | May 27, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription